Diagnocare Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 25-12-2024
- Paid Up Capital ₹ 0.20 M
as on 25-12-2024
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 677.75%
(FY 2022)
- Profit 168.17%
(FY 2022)
- Ebitda 173.86%
(FY 2022)
- Net Worth 257.31%
(FY 2022)
- Total Assets 360.82%
(FY 2022)
About Diagnocare Life Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Vikas Kothari, Shakuntala Kothari, and Rachana Jain serve as directors at the Company.
- CIN/LLPIN
U51909TN2020PTC139146
- Company No.
139146
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Nov 2020
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Diagnocare Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikas Kothari  | Director | 02-Nov-2020 | Current |
| Shakuntala Kothari | Director | 02-Nov-2020 | Current |
| Rachana Jain | Director | 02-Nov-2020 | Current |
Financial Performance of Diagnocare Life Sciences.
Diagnocare Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 677.75% increase. The company also saw a substantial improvement in profitability, with a 168.17% increase in profit. The company's net worth Soared by an impressive increase of 257.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diagnocare Life Sciences?
In 2022, Diagnocare Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Diagnocare Life Sciences?
Diagnocare Life Sciences has a workforce of 27 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diagnocare Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diagnocare Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
